Company Filing History:
1 out of 337 
1 out of 1 Years Active: 2011-2014
Title: Innovations by Jae-Yong Park: Pioneering Diagnostic Biomarkers and Therapeutic Peptides
Introduction
Jae-Yong Park is an accomplished inventor based in Daegu, South Korea. He has made significant contributions to the field of biomedical research, particularly in the development of diagnostic biomarkers and therapeutic peptides. With a total of two patents to his name, his work has the potential to impact the diagnosis and treatment of serious health conditions.
Latest Patents
One of Jae-Yong Park's latest patents focuses on plasma kallikrein fragments as diagnostic biomarkers for lung cancers. This invention discloses diagnostic markers isolated from serum glycoproteins that are specifically expressed at high levels in the sera of lung cancer patients. These markers are expected to be highly useful for diagnosing lung cancer and estimating disease progression and treatment.
His second patent involves the use of a peptide that interacts with the αvβ3 integrin of endothelial cells. This invention relates to a method for inhibiting endothelial cell adhesion, migration, and angiogenesis using a peptide consisting of at least 18 amino acids, which includes tyrosine-histidine (TY) or asparagines-histidine (NH), along with at least three hydrophobic amino acids with bulky side chains. Furthermore, this invention provides a method for treating or preventing angiogenesis-related diseases using the peptide.
Career Highlights
Jae-Yong Park has worked with notable institutions, including the Kyungpook National University Industry-Academic Cooperation Foundation and Protan Bio Co., Ltd. His experience in these organizations has allowed him to collaborate on various innovative projects that bridge the gap between academic research and practical applications in the industry.
Collaborations
Some of his notable coworkers include Ju-Ock Nam and Jung-Eun Kim. Their collaborative efforts have contributed to the advancement of research in their respective fields.
Conclusion
Jae-Yong Park's innovative work in developing diagnostic biomarkers and therapeutic peptides showcases his commitment to advancing medical science. His contributions have the potential to significantly improve the diagnosis and treatment of lung cancer and related diseases.